Strategies for the identification of allosteric modulators of G-protein-coupled receptors
NT Burford, J Watson, R Bertekap, A Alt - Biochemical pharmacology, 2011 - Elsevier
Once considered a pharmacological curiosity, allosteric modulation of seven
transmembrane domain G-protein-coupled receptors (GPCRs) has emerged as a potentially …
transmembrane domain G-protein-coupled receptors (GPCRs) has emerged as a potentially …
Targeting chemokine receptors in allergic disease
JE Pease - Biochemical Journal, 2011 - portlandpress.com
The directed migration of cells in response to chemical cues is known as chemoattraction,
and plays a key role in the temporal and spatial positioning of cells in lower-and higher …
and plays a key role in the temporal and spatial positioning of cells in lower-and higher …
Chemokines and their receptors in the allergic airway inflammatory process
JR Velazquez, LM Teran - Clinical reviews in allergy & immunology, 2011 - Springer
The development of the allergic airway disease conveys several cell types, such as T-cells,
eosinophils, mast cells, and dendritic cells, which act in a special and temporal …
eosinophils, mast cells, and dendritic cells, which act in a special and temporal …
Diagnosis of eosinophilic esophagitis based on presence of an elevated level of eotaxin-3
ME Rothenberg - US Patent 8,030,003, 2011 - Google Patents
US8030003B2 - Diagnosis of eosinophilic esophagitis based on presence of an elevated level
of eotaxin-3 - Google Patents US8030003B2 - Diagnosis of eosinophilic esophagitis based on …
of eotaxin-3 - Google Patents US8030003B2 - Diagnosis of eosinophilic esophagitis based on …
Therapeutic potential of CCR1 antagonists for multiple myeloma
AR Karash, A Gilchrist - Future Medicinal Chemistry, 2011 - Future Science
The chemokine receptor CCR1 has been the target of intensive research for nearly two
decades. Small-molecule antagonists were first reported in 1998 and, since then, many …
decades. Small-molecule antagonists were first reported in 1998 and, since then, many …
First Pharmacophore Model of CCR3 Receptor Antagonists and its Homology Model‐Assisted, Stepwise Virtual Screening
V Jain, P Saravanan, A Arvind… - Chemical biology & drug …, 2011 - Wiley Online Library
CCR3, a G protein‐coupled receptor, plays a central role in allergic inflammation and is an
important drug target for inflammatory diseases. To understand the structure–function …
important drug target for inflammatory diseases. To understand the structure–function …
Chemokines
LM Teran, JR Velazquez - Inflammation and Allergy Drug …, 2011 - Wiley Online Library
The pathogenesis of allergic inflammation is complex, involving multiple cell types such as
type II T helper cells, regulatory T cells, eosinophils, dendritic cells, mast cells, and structural …
type II T helper cells, regulatory T cells, eosinophils, dendritic cells, mast cells, and structural …
Cytokines and chemokines as therapeutic targets for ischemic kidney injury
K Furuichi, T Wada, S Kaneko - Inflammation and Regeneration, 2011 - jstage.jst.go.jp
Cytokines and chemokines play important roles in the progression of ischemic kidney injury.
Previous reports indicated that cytokines and chemokines participate in unique pathological …
Previous reports indicated that cytokines and chemokines participate in unique pathological …
Interaction cytokines/glycosaminoglycanes comme cible d'une nouvelle approche thérapeutique
M Prull-Janssen - 2011 - theses.hal.science
Les interactions non covalentes entre cytokines et glycosaminoglycanes interviennent dans
de nombreux processus physiologiques, tels que la signalisation et la reconnaissance …
de nombreux processus physiologiques, tels que la signalisation et la reconnaissance …